IL4 and neoplasm: This IHC result was validated by immunoblotting analysis of tumor bearing glands, which showed abundant levels of Arg1 protein in IL4-AC2M2 tumors, but no detectable Arg1 in EV-AC2M2 tumors or normal mammary glands (Supplementary Figure 6).